Osimertinib was approved for medical use in the United States in November 2015.
Domain | azd9291inhibitor.com |
---|---|
Homepage URL | https://azd9291inhibitor.com/chronic-neurologic-signs-or-symptoms-along-with-cognitive-problems-within-non-hospitalized-covid-19-long-haulers/ |
Keywords | azd9291 inhibitor protein inhibitors heredity research |
Sprache | englisch |